An international survey seeks to determine the most important outcomes to measure in Phase 3 trials of pulmonary TB treatment.

The UNITE4TB Consortium is proud to announce the start of its phase 2B/C clinical trial program. The announcement is a major milestone for the project and the TB community as a whole, helping to advance TB science and enhance the efficiency with which new treatments are delivered.